EBODAC SIGNED
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment – Sofia ref.: 115847
Total Cost €
0EC-Contrib. €
0Partnership
0Views
0EBODAC project word cloud
Explore the words cloud of the EBODAC project. It provides you a very rough idea of what is the project "EBODAC" about.
Project "EBODAC" data sheet
The following table provides information about the project.
| Coordinator |
LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER
Organization address contact info |
| Coordinator Country | United Kingdom [UK] |
| Project website | http://www.ebovac.org/ebodac/ |
| Total cost | 20˙402˙786 € |
| EC max contribution | 20˙328˙856 € (100%) |
| Programme |
1. H2020-EU.3.1.7. (Innovative Medicines Initiative 2 (IMI2)) |
| Code Call | H2020-JTI-IMI2-2014-02-single-stage |
| Funding Scheme | IMI2-RIA |
| Starting year | 2014 |
| Duration (year-month-day) | from 2014-12-01 to 2020-11-30 |
Partnership
Take a look of project's partnership.
| # | ||||
|---|---|---|---|---|
| 1 | LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE ROYAL CHARTER | UK (LONDON) | coordinator | 3˙380˙902.00 |
| 2 | WORLD VISION OF IRELAND LBG | IE (DUBLIN 6) | participant | 13˙493˙437.00 |
| 3 | GRAMEEN FOUNDATION USA | US (WASHINGTON) | participant | 3˙454˙515.00 |
| 4 | JANSSEN PHARMACEUTICA NV | BE (BEERSE) | participant | 0.00 |
Map
Project objective
Communication strategy and tools for optimizing the impact of Ebola vaccination deployment.
The EBODAC consortium consists of 4 partners: Janssen (EFPIA), London School of Hygiene and Tropical Medicine (LSHTM), World Vision of Ireland and Grameen Foundation . These partners have experience and expertise in:
• (Ebola) vaccine development and vaccine acceptance; m-health deployments for disease management in resource limited settings (Janssen) • Vaccine acceptance; risk management in health programs (LSHTM) • Mobile health deployments for emergency assistance; communication and training delivery in emergency settings (World Vision) • Mobile health software development and deployment in resource limited settings (Grameen)
As such, the EBODAC consortium is well placed to tackle the challenges associated with Ebola vaccine deployment, including: • Stigma related to Ebola infections • Lack of understanding and distrust versus vaccines in general in the local endemic communities • Two step prime/booster regimen for Ebola vaccine: risk for a ‘no show’ for the booster shot, risk for presenting for the booster shot too early or too late; risk for a different person presenting for the booster shot vs. the prime shot • People may be difficult to reach for the vaccine recall; People may live at a large distance from the health center where the vaccine is delivered • Risk for data on vaccine coverage to be fragmented, not existing or incorrect
The EBODAC consortium is committed to deliver: • A communication strategy that will optimize vaccine acceptance, supported by local anthropology research data • A platform, based on mobile phone technology, for Ebola vaccine recalls, information/education on Ebola and vaccines in general; and tracking of vaccination coverage • An identification tool to allow to match the identity of individuals in the prime and boost vaccine regimens • A training program in the local setting, and a helpdesk function, to support the m-health platform
Deliverables
| Test identification tool ready (for trial) | Demonstrators, pilots, prototypes | 2019-11-15 10:09:01 |
| Final platform ready (trial) | Other | 2019-11-15 10:09:01 |
| Technology components integrated (trial) | Other | 2019-11-15 10:09:01 |
| All privacy, regulatory and policy elements taken into account for trial (for each geography) | Documents, reports | 2019-11-15 10:09:01 |
| Technical deployment elements ready (trial)(for each geography) | Other | 2019-11-15 10:09:01 |
| Iris-Scan study including data | Documents, reports | 2019-11-15 10:09:01 |
| Content for Mobile Training and Support Service for health;workers ready | Documents, reports | 2019-11-15 10:09:01 |
| Message content developed for trial | Documents, reports | 2019-11-15 10:09:01 |
| Overview of data flow (for trial) | Documents, reports | 2019-11-15 10:09:01 |
| Test platform ready (trial) | Demonstrators, pilots, prototypes | 2019-11-15 10:09:01 |
Take a look to the deliverables list in detail: detailed list of EBODAC deliverables.
Publications
| year | authors and title | journal | last update |
|---|---|---|---|
| 2019 |
Serge Masyn, Anneleen Vuchelen, Eva Santermans, Freya Rasschaert, Allieu Bangura, Wim Parys, Romain Rutten Overcoming the challenges of iris scanning to identify minors (1–4 years) in the real-world setting published pages: , ISSN: 1756-0500, DOI: 10.1186/s13104-019-4485-8 |
BMC Research Notes 12/1 | 2020-03-05 |
| 2019 |
Paula Mc Kenna, Geoffrey Babughirana, Monica Amponsah, Seth Gogo Egoeh, Evelyne Banura, Robert Kanwagi, Bobbi Gray Mobile training and support (MOTS) service—using technology to increase Ebola preparedness of remotely-located community health workers (CHWs) in Sierra Leone published pages: 35-35, ISSN: 2306-9740, DOI: 10.21037/mhealth.2019.09.03 |
mHealth 5 | 2020-03-05 |
| 2017 |
Geoffrey Babughirana, Robert Kanwagi (World Vision) Making enabling technologies work in Prime-Boost vaccination programs published pages: , ISSN: , DOI: |
2019-11-15 | |
| 2016 |
Luisa Enria, Shelley Lees, Elizabeth Smout, Thomas Mooney, Angus F. Tengbeh, Bailah Leigh, Brian Greenwood, Deborah Watson-Jones, Heidi Larson Power, fairness and trust: understanding and engaging with vaccine trial participants and communities in the setting up the EBOVAC-Salone vaccine trial in Sierra Leone published pages: , ISSN: 1471-2458, DOI: 10.1186/s12889-016-3799-x |
BMC Public Health 16/1 | 2019-11-15 |
| 2017 |
Per Egil Kummervold, William S. Schulz, Elizabeth Smout, Luis Fernandez-Luque, Heidi J. Larson Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news published pages: , ISSN: 1471-2458, DOI: 10.1186/s12889-017-4618-8 |
BMC Public Health 17/1 | 2019-11-15 |
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EBODAC" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "EBODAC" are provided by the European Opendata Portal: CORDIS opendata.
More projects from the same programme (H2020-EU.3.1.7.)
RespiriNTM (2019)
Progress novel assets (one FIH start) for non-tubercular mycobacteria that may act synergistically with bedaquiline and cytochrome bc drugs
Read More